Selective Use of Cyclosporine for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis May Exclude Patients with Poor Prognostic Factors

J Invest Dermatol. 2018 Sep;138(9):2068-2072. doi: 10.1016/j.jid.2018.03.1496. Epub 2018 Mar 17.

¹ Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
² Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
³ Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
⁴ Department of Dermatology University of California-San Francisco, San Francisco, California, USA.
⁵ Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. Electronic address: robert.micheletti@uphs.upenn.edu.

No abstract available

Publication types